Magnum Ice Cream officially spun off from Unilever earlier this month, debuting on the Amsterdam Stock Exchange with a market capitalization of approximately €7.8 billion ($9.1 billion). Despite holding the position as the world’s largest standalone ice cream company, Magnum’s shares have traded at a contrarian 35-40% discount compared to sector peers, driven by early selling from index-linked investors. Kepler Cheuvreux analyst Karel Zoete has initiated coverage with a Buy rating and a €16.30 target price, signaling close to 19% potential upside from current levels.

Market Reaction and Analyst Insights

Following Magnum’s separation, the stock saw notable selling pressure as index-tracking funds reduced holdings, causing the share price to lag intrinsic valuation. Zoete highlights that this undervaluation overlooks Magnum’s global leadership, steady sales momentum, and promising margin recovery. The firm currently trades at around 12 times forecasted 2026 earnings and 11 times EBIT, attractive multiples in Zoete’s view. Even at the €16.30 target, shares would remain roughly 25% cheaper than competing firms, presenting a compelling contrarian buy opportunity during a shareholder base transition.

Zoete draws on a 20-year sales CAGR of 3.8% for Unilever’s former ice cream division in euros, underscoring a long-term growth backdrop. Additionally, he points to like-for-like sales growth near 5% year-to-date and regained market share over the past year—performance metrics that outpace the broader ice cream sector’s 3–4% annual expansion.

Operational Efficiency and Margin Recovery Drive

At the core of the contrarian thesis is Magnum’s margin improvement potential. The company has initiated a €500 million productivity program aimed at elevating operational efficiency. While 2026 will still entail headwinds, including separation expenses, increased IT costs, and acquisition-related dilution, Zoete anticipates meaningful EBITDA growth over the medium term. He stresses that prior to the spin-off, Magnum’s operating model was suboptimal. The analyst expects the company to eventually achieve EBITDA margins around 20%, significantly above current levels.

Although GAAP profits and free cash flow may remain volatile into 2026, Zoete remains optimistic about ongoing operational upgrades and margin expansion. He views this transitional phase as an opportunity for investors seeking a contrarian exposure to a large global leader undergoing a value-enhancing turnaround.

Contrarian Opportunity in Consumer Staples

Magnum Ice Cream’s IPO and subsequent share-price discount present a clear contrarian investment theme in the consumer staples domain. As a newly independent market leader with proven sales growth and operational initiatives underway, the company’s shares offer meaningful upside from depressed valuations. Investors acknowledging the discrepancy between current pricing and Magnum’s latent potential may find a rare entry point in a stable sector.